Ryaltris is not discontinued. The medication is approved and available for treating symptoms associated with allergic rhinitis.
When did Ryaltris get approved?
Ryaltris received approval from the U.S. Food and Drug Administration (FDA) in March 2021 [1].
What is Ryaltris used for?
Ryaltris is a nasal spray used to treat nasal and ocular symptoms of seasonal allergic rhinitis in patients 12 years of age and older [1]. It is also indicated for the treatment of nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older [1]. The drug combines olopatadine, an antihistamine, and mometasone furoate, a corticosteroid [2].
How does Ryaltris work?
Ryaltris works by delivering olopatadine hydrochloride and mometasone furoate directly to the nasal passages. Olopatadine hydrochloride is an H1-receptor antagonist that blocks the action of histamine, a substance released during an allergic reaction that causes symptoms like sneezing and itching. Mometasone furoate is a corticosteroid that helps to reduce inflammation in the nasal lining, alleviating congestion and other inflammatory symptoms [2].
What are the potential side effects of Ryaltris?
Common side effects reported with Ryaltris include headache, nasal discomfort, nosebleeds, and bitter taste [1].
How does Ryaltris compare to other allergy medications?
Ryaltris offers a combination therapy approach, delivering both an antihistamine and a corticosteroid in a single nasal spray. This can be convenient for patients managing multiple allergy symptoms. Other treatment options for allergic rhinitis include oral antihistamines, nasal corticosteroid sprays, and decongestants, each with their own mechanisms of action and potential side effects [3].
What is the patent status for Ryaltris?
Information regarding specific patent expirations for Ryaltris can be found on platforms like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [4].
Who manufactures Ryaltris?
Ryaltris is manufactured by OptiNose US, Inc. [1].
---
Sources:
1. \https://www.drugs.com/ryaltris.html
2. \https://www.rxlist.com/ryaltris-drug.htm
3. \https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351115
4. \https://drugpatentwatch.com/